195 related articles for article (PubMed ID: 38760813)
1. Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface.
Liu S; Wen H; Li F; Xue X; Sun X; Li F; Hu R; Xi H; Boccellato F; Meyer TF; Mi Y; Zheng P
J Transl Med; 2024 May; 22(1):468. PubMed ID: 38760813
[TBL] [Abstract][Full Text] [Related]
2. DKK1 is epigenetically downregulated by promoter methylation and inhibits bile acid-induced gastric intestinal metaplasia.
Lu W; Ni Z; Tong M; Jiang S; Zhang J; Feng C; Han C; Yuan T; Wang N; Zhao J; Sun N; Liu C; Jia Q; Wu Q; Ning H; Shi Y
Biochem Biophys Res Commun; 2020 Mar; 523(3):780-786. PubMed ID: 31952791
[TBL] [Abstract][Full Text] [Related]
3. Gastric Intestinal Metaplasia in Mucosa Adjacent to Gastric Cancers Is Rarely Associated With the Aneuploidy That Is Characteristic of Gastric Dysplasia or Cancer.
Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Am J Surg Pathol; 2021 Oct; 45(10):1374-1381. PubMed ID: 34091484
[TBL] [Abstract][Full Text] [Related]
4. Potential role of aquaporin 3 in gastric intestinal metaplasia.
Zhao H; Yang X; Zhou Y; Zhang W; Wang Y; Wen J; Zhang Z; Shen L
Oncotarget; 2015 Nov; 6(36):38926-33. PubMed ID: 26506416
[TBL] [Abstract][Full Text] [Related]
5. Screening key genes and biomarkers in gastrointestinal metaplasia that progress to gastric cancer by integrated bioinformatics analysis.
Pang L; Yan X; Su D
J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35485356
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.
Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH
Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693
[TBL] [Abstract][Full Text] [Related]
7. Gastric intestinal metaplasia: progress and remaining challenges.
Tong QY; Pang MJ; Hu XH; Huang XZ; Sun JX; Wang XY; Burclaff J; Mills JC; Wang ZN; Miao ZF
J Gastroenterol; 2024 Apr; 59(4):285-301. PubMed ID: 38242996
[TBL] [Abstract][Full Text] [Related]
8. Modified Chaishao Liujunzi Decoction inhibits bile acid-induced gastric intestinal metaplasia: from network prediction to experimental verification.
Sun Z; Liu Y; Deng H; Wang S; Zhang J; Xing C; Xu C
Aging (Albany NY); 2023 Dec; 15(23):13998-14018. PubMed ID: 38096029
[TBL] [Abstract][Full Text] [Related]
9. GATA4 Forms a Positive Feedback Loop with CDX2 to Transactivate MUC2 in Bile Acids-Induced Gastric Intestinal Metaplasia.
Yang X; Ye T; Rong L; Peng H; Tong J; Xiao X; Wan X; Guo J
Gut Liver; 2024 May; 18(3):414-425. PubMed ID: 36860162
[TBL] [Abstract][Full Text] [Related]
10. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer?
Sugano K; Moss SF; Kuipers EJ
Gastroenterology; 2023 Dec; 165(6):1352-1366.e1. PubMed ID: 37652306
[TBL] [Abstract][Full Text] [Related]
11. Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?
Kutluana U; Kilciler AG; Mizrak S; Dilli U
Gastroenterol Hepatol; 2019 May; 42(5):289-295. PubMed ID: 30795853
[TBL] [Abstract][Full Text] [Related]
12. Bile reflux and bile acids in the progression of gastric intestinal metaplasia.
Qu X; Shi Y
Chin Med J (Engl); 2022 Jul; 135(14):1664-1672. PubMed ID: 35940882
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions.
Huang RJ; Choi AY; Truong CD; Yeh MM; Hwang JH
Gut Liver; 2019 Nov; 13(6):596-603. PubMed ID: 31394893
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of a field defect in gastric intestinal metaplasia by biological marker analysis.
Garewal HS; Fennerty B; Sampliner R; Ramsey L
Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):683-6. PubMed ID: 7881342
[TBL] [Abstract][Full Text] [Related]
15. Confocal laser endomicroscopy for in vivo detection of gastric intestinal metaplasia: a randomized controlled trial.
Li Z; Zuo XL; Yu T; Gu XM; Zhou CJ; Li CQ; Ji R; Li YQ
Endoscopy; 2014 Apr; 46(4):282-90. PubMed ID: 24473908
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of olfactomedin 4 as a molecular biomarker for early diagnosis of gastric neoplasia after intestinal metaplasia.
Pang L; Yan X; Su D; Wu X; Jiang H
Scand J Gastroenterol; 2023 Feb; 58(2):133-141. PubMed ID: 36124708
[TBL] [Abstract][Full Text] [Related]
17. Preferential expression of cyclooxygenase-2 in colonic-phenotype of gastric intestinal metaplasia: association with helicobacter pylori and gastric carcinoma.
Sun JH; Das KK; Amenta PS; Yokota K; Watari J; Sato T; Kohgo Y; Das KM
J Clin Gastroenterol; 2006 Feb; 40(2):122-8. PubMed ID: 16394872
[TBL] [Abstract][Full Text] [Related]
18. From part to whole, operative link on to endoscopic grading of gastric intestinal metaplasia, pathology to endoscopy: gastric intestinal metaplasia graded by endoscopy.
Wei N; Zhou M; Lei S; Yang L; Duan Z; Zhang Y; Zhong Z; Liu Y; Shi R
Future Oncol; 2022 Jun; 18(19):2445-2454. PubMed ID: 35574611
[No Abstract] [Full Text] [Related]
19. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body.
O'Connor A; Bowden A; Farrell E; Weininger J; Crowther S; McNamara D; Ridgway P; O'Morain C
Dig Dis Sci; 2021 Oct; 66(10):3470-3475. PubMed ID: 33094451
[TBL] [Abstract][Full Text] [Related]
20. Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.
Forné M; Fernández-Bañares F; González-Mínguez C; Casalots J; Poblet-Mas N; Garcia-Gil LJ; Esteve M; Rosinach M; Espinós J; Loras C; Salas A; Viver JM
Am J Clin Pathol; 2009 Jan; 131(1):99-105. PubMed ID: 19095572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
